Nope. Wrong on your ASX requirement. No more more a requirement than a company calling a new debt undertaking - after all simply a method of raising capital - a capital raise.
Such a pointless argument. How about we wait and see and simply hope the strategic share placement is with an investor we feel favourable to both the share price and/or the underlying business? I personally dare not hope for someone like J&J or Zimmer Biomet, but then again I never expected Paul "I'm excited" Anderson to pull Bio Horizons out of the bag - he confounded all with that one to his very commendable credit.
Ann: Trading Halt, page-34
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
-0.020(3.03%) |
Mkt cap ! $132.0M | |||
| Open | High | Low | Value | Volume |
| 68.0¢ | 69.5¢ | 60.5¢ | $929.8K | 1.459M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3158 | 64.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.0¢ | 13284 | 5 |
View Market Depth
| Last trade - 14.39pm 14/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |